Literature DB >> 10576433

Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps.

R A Floyd1, K Hensley, F Jaffery, L Maidt, K Robinson, Q Pye, C Stewart.   

Abstract

Nitrone-based free radical traps (NFTs) have been shown to be protective in several neurodegenerative models. Our research has strongly implicated that: A) several neurodegenerative conditions exhibit increased levels of pro-inflammatory cytokines which consequently result in increased levels of oxidative stress and B) that NFTs act in part by suppressing oxidative stress through suppression of the action of the cytokine cascade. Acquired Immune Deficiency Syndrome (AIDS) dementia complex (ADC) is one of several conditions where the data collected helped to develop these concepts. Novel observations include demonstration that IL-1beta acts on cultured brain glia cells to invoke protein nitration and oxidative stress and that low levels of PBN (alpha-phenyl tert-butyl nitrone) inhibit this effect. We interpret these data as indicating that PBN prevents IL-1beta mediated peroxynitrite formation. Additionally, we have found that the AIDS viral envelope protein gp120 upregulates mRNA for the cytokines TNF alpha and TNF beta in rat neonatal brain, and that PBN prevents this. Western blots of protein extracts showed upregulation of inducible nitric oxide synthase (iNOS) in gp120 treated neonatal rat brains, and that PBN prevented induction of this enzyme as well. These observations underscore the general concept that PBN inhibits the induction of genes which produce neurotoxic products, one of which is peroxynitrite formed by the reaction of nitric oxide with superoxide, and may act also by inhibiting the induction of cytokines which mediate pro-inflammatory conditions in the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10576433     DOI: 10.1016/s0024-3205(99)00443-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 2.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

Review 4.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.

Authors:  Guy C Brown; Anna Bal-Price
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

5.  Parental responsiveness moderates the association between early-life stress and reduced telomere length.

Authors:  A Asok; K Bernard; T L Roth; J B Rosen; M Dozier
Journal:  Dev Psychopathol       Date:  2013-03-26

6.  Neuroprotection by S-PBN in hyperglycemic ischemic brain injury in rats.

Authors:  Maria Molnar; Fredrik Lennmyr
Journal:  Ups J Med Sci       Date:  2010-08       Impact factor: 2.384

7.  Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines.

Authors:  Shun-Guang Wei; Zhi-Hua Zhang; Terry G Beltz; Yang Yu; Alan Kim Johnson; Robert B Felder
Journal:  Hypertension       Date:  2013-05-13       Impact factor: 10.190

Review 8.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

9.  The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Authors:  M J Ferris; D Frederick-Duus; J Fadel; C F Mactutus; R M Booze
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

10.  Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration.

Authors:  Alison J B Markowitz; Michael G White; Dennis L Kolson; Kelly L Jordan-Sciutto
Journal:  Cellscience       Date:  2007-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.